LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM

Reporting ownerCIK 0001786304

John M. Evans

35 transactions in one company, from January 29, 2026 to October 16, 2026.

Transactions: 351 company
Bought · P: $0open market
Sold · S: $6.2Mopen market
Net: −$6.2Mnet selling

By company

Where this insider traded.

Company	Ticker	Trades	Bought	Sold
Beam Therapeutics Inc.	BEAM	35	—	$6.2M

All transactions

35 in total, newest filings first.

Company	Ticker	Insider	Date	Code	Shares	Price	Value
Beam Therapeutics Inc.	BEAM	John M. EvansCEODERIV	Oct 16	MPLAN	25,000	$0.00	—?
Beam Therapeutics Inc.	BEAM	John M. EvansCEODERIV	Oct 15	MPLAN	25,000	$0.00	—?
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Oct 16	SPLAN	25,000	$23.98	$600K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Oct 16	MPLAN	25,000	$1.03	$26K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Oct 15	SPLAN	25,000	$23.57	$589K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Oct 15	MPLAN	25,000	$1.03	$26K
Beam Therapeutics Inc.	BEAM	John M. EvansCEODERIV	Jun 30	MPLAN	25,000	$0.00	—?
Beam Therapeutics Inc.	BEAM	John M. EvansCEODERIV	Jun 29	MPLAN	6,337	$0.00	—?
Beam Therapeutics Inc.	BEAM	John M. EvansCEODERIV	Jun 29	MPLAN	18,663	$0.00	—?
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Jun 30	SPLAN	1,900	$34.84	$66K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Jun 30	SPLAN	23,100	$34.26	$791K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Jun 30	MPLAN	25,000	$1.03	$26K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Jun 29	SPLAN	11,579	$35.91	$416K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Jun 29	SPLAN	13,421	$35.13	$472K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Jun 29	MPLAN	6,337	$1.03	$7K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Jun 29	MPLAN	18,663	$0.67	$13K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Apr 1	SPLAN	30,078	$24.58	$739K
Beam Therapeutics Inc.	BEAM	John M. EvansCEODERIV	Mar 31	MPLAN	25,000	$0.00	—?
Beam Therapeutics Inc.	BEAM	John M. EvansCEODERIV	Mar 30	MPLAN	25,000	$0.00	—?
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Mar 31	APLAN	90,000	$0.00	—
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Mar 31	SPLAN	25,000	$22.76	$569K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Mar 31	MPLAN	25,000	$0.67	$17K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Mar 30	SPLAN	25,000	$22.37	$559K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Mar 30	MPLAN	25,000	$0.67	$17K
Beam Therapeutics Inc.	BEAM	John M. EvansCEODERIV	Jan 31	APLAN	180,000	$0.00	—?
Beam Therapeutics Inc.	BEAM	John M. EvansCEODERIV	Jan 30	MPLAN	25,000	$0.00	—?
Beam Therapeutics Inc.	BEAM	John M. EvansCEODERIV	Jan 29	MPLAN	5,664	$0.00	—?
Beam Therapeutics Inc.	BEAM	John M. EvansCEODERIV	Jan 29	MPLAN	19,336	$0.00	—?
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Jan 30	SPLAN	2,906	$29.00	$84K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Jan 30	SPLAN	22,094	$28.27	$625K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Jan 30	MPLAN	25,000	$0.67	$17K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Jan 29	SPLAN	8,667	$29.74	$258K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Jan 29	SPLAN	16,333	$29.19	$477K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Jan 29	MPLAN	5,664	$0.67	$4K
Beam Therapeutics Inc.	BEAM	John M. EvansCEO	Jan 29	MPLAN	19,336	$0.67	$13K